Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19

Table 1 Study population characteristics at six-month follow-up by age group

	< 75 years old n = 61	≥ 75 years old n = 45	p-value
Age (mean, SD)	68.4 (4.6)	82.4 (5.3)	< 0.05
Age (mean, SD)	n (%)	n (%)
Male gender	37 (61)	23 (51)	0.33
Current or previous smoking^a	30 (50)	26 (59)	0.36
Severe acute disease^b	22 (36)	5 (11)	< 0.05
Length of hospital stay (mean, SD)	12.5 (12.5)	10.3 (12.1)	0.37
Work status^c			< 0.05
Full-time or part-time employed	18 (30)	0 (0)
Sick leave, retirement or disability advantages	42 (69)	45 (100)
Comorbidities
Hypertension	22 (36)	19 (42)	0.52
Cardiac conditions	12 (20)	22 (49)	< 0.05
COPD^d or asthma	18 (30)	11 (24)	0.56
Diabetes mellitus	10 (16)	6 (13)	0.66
Dementia	0 (0)	5 (11)	< 0.05
Obesity (BMI > 30)^e	16 (28)	6 (16)	0.20
Other^f	9 (15)	14 (31)	< 0.05
Cognitive capacity	Mean (SD)	Mean (SD)
MoCA total score (0–30)^g	25.3 (3.8)	21.7 (5.8)	< 0.05
Functional capacity
SPPB total score (0–12)^h	10.6 (2.3)	7.8 (3.1)	< 0.05

Patients aged 60 years and older admitted to four Norwegian hospitals from March 1 to July 1, 2020 due to COVID-19, and still alive after 6 months, n = 106
^aMissing data for 2 patients
^bAdmission to intensive care unit or intermediary ward during hospitalisation
^cMissing data for 1 patient
^dChronic obstructive pulmonary disease
^eMissing data for 11 patients
^fIncluding active cancer, previous depression, chronic kidney disease or previous brain stroke
^gIncomplete or missing data for 14 participants
^hSix patients did not perform the SPPB

ISSN: 1471-2318